S H hand1 hand2 handcombind R E

TARGET-ID: Undiagnosed HIV, Hepatitis B and Hepatitis C in primary care

Targeted testing using digital technology to increase identification and improve care pathways for people at risk and underserved communities

Funded by NIHR School for Primary Care Research

Overview

Identifying people living with blood-borne viruses (BBV) remains a challenge.

Up to 1 in 20 people who are living with HIV and almost half of those living with Hepatitis B (HBV) or Hepatitis C (HCV) are unaware of this. New approaches are urgently needed to diagnose people and link them to treatment earlier, to improve their health outcomes and limit passing it on to others.

TARGET-ID is an NIHR SPCR-funded a cross-disciplinary, expert/lay programme, promoting targeted, combined (HIV-HBV-HCV) BBV testing in primary care, using a risk-score algorithm to identify people at highest risk of acquisition, combined with peer support for those diagnosed to promote effective linkage to care and treatment.

We bring together people with lived experience of having BBVs and representatives of leading Hepatitis and HIV clinicians and organisations, with experts in statistical and epidemiological modelling, risk-score modellers, experts in intervention development and implementation, and qualitative, quantitative and economic evaluation, to co-create and co-evaluate this programme.

Meet the TARGET-ID Team

Dr Werner Leber 
Chief Investigator
w.leber@qmul.ac.uk

Prof Chris Griffiths
Professor in Primary Care
c.j.griffiths@qmul.ac.uk

Prof Jane Anderson 
Honorary Professor in HIV Medicine
janderson@nhs.net

Meet the team

TARGET-ID work and progress

TBC

TARGET-ID publications and outputs

TBC